Google AI ModeSep 6, 2026
Orexo, Click Therapeutics, and Better Therapeutics: These companies have secured various levels of commercial health plan coverage
Loading…
Orexo is a pharmaceutical company that develops and commercializes treatments using its proprietary AmorphOX drug delivery technology to improve bioavailability and stability. The company's pipeline includes OX640, a nasal epinephrine solution designed for anaphylaxis rescue.
AI named Orexo from December 2025 to September 2026.
Question: Which digital therapeutics companies have achieved reimbursement codes from payers?
Google AI ModeSep 6, 2026
Orexo, Click Therapeutics, and Better Therapeutics: These companies have secured various levels of commercial health plan coverage
Question: Which digital therapeutics companies have achieved reimbursement codes from payers?
Google AI ModeAug 25, 2026
Orexo / Click Therapeutics / Reset-developer lineage – Companies with FDA-cleared software targeting substance use disorders (SUD) and opioid use disorder (OUD) fit squarely into the therapeutic categories
Akili Interactive, EndeavorRx, and Click Therapeutics appeared in every answer that named
None of these answers cited orexo.com. AI leaned on healthaffairs.org, odelletechnology.com, and aapc.com.
orexo.com 0%Other sites 100%
Excerpts where Orexo appeared in the AI's answer
Orexo, Click Therapeutics, and Better Therapeutics: These companies have secured various levels of commercial health plan coverage
Orexo / Click Therapeutics / Reset-developer lineage – Companies with FDA-cleared software targeting substance use disorders (SUD) and opioid use disorder (OUD) fit squarely into the therapeutic categories
